Arcari et al.
|
hs-TnT, hs-TnI
|
Roche, NA
|
14 ng/L, 35 ng/L
|
Within 24 h of admission
|
103/111 (92.8)
|
39/103 (37.9)
|
Azoulay et al.
|
NA
|
NA
|
NA
|
On ICU admission
|
343/379 (90.5)
|
135/343 (39.4)
|
Barman et al.
|
hs-TnI
|
NA
|
14 ng/L
|
On admission
|
607/908 (66.9)
|
150/607 (24.7)
|
Bhatla et al.
|
NA
|
NA
|
0.010 ng/mL
|
On admission
|
373/700 (53.3)
|
82/373 (22.0)
|
Bhatraju et al.
|
NA
|
NA
|
0.06 ng/mL
|
During first 3 days in ICU
|
13/24 (54.2)
|
2/13 (15.4)
|
Buckner et al.
|
NA
|
NA
|
0.1 ng/mL
|
During hospitalisation
|
67/105 (63.8)
|
13/67 (19.4)
|
Cipriani et al.
|
hs-TnI
|
NA
|
32 ng/L for men, 16 ng/L for women
|
On admission and during hospitalisation
|
109/136 (80.1)
|
On admission, 41/109 (37.6); overall, 46/109 (42.2)
|
Du et al.
|
TnI
|
NA
|
0.05 ng/mL
|
On admission
|
179/179 (100)
|
41/179 (22.9)
|
Ferguson et al.
|
NA
|
NA
|
0.055 ng/mL
|
Within 24 h of admission
|
45/72 (62.5)
|
2/45 (4.4)
|
Franks et al.
|
TnI
|
Abbott
|
0.03 ng/mL
|
On admission and during hospitalisation
|
On admission, 128/182 (70.3); overall, 143/182 (78.6)
|
On admission, 65/128 (50.8); overall, 80/143 (55.9)
|
Gottlieb et al.
|
NA
|
NA
|
0.9 ng/mL
|
On admission
|
390/1483 (26.3)
|
87/390 (22.3)
|
Goyal et al.
|
NA
|
NA
|
0.5 ng/mL
|
Within 48 h of admission
|
246/393 (62.6)
|
11/246 (4.5)
|
Harmouch et al.
|
TnI
|
NA
|
0.05 ng/mL
|
On admission
|
482/560 (86.1)
|
97/482 (20.1)
|
He et al.
|
hs-TnI
|
NA
|
NA
|
During stay in ICU
|
94/94 (100)
|
35/94 (37.2)
|
Heberto et al.
|
hs-TnI
|
Beckman
|
17.5 ng/L
|
On admission
|
254/254 (100)
|
64/254 (25.2)
|
Hu et al.
|
TnI
|
Siemens
|
0.040 ng/mL
|
On admission
|
323/323 (100)
|
68/323 (21.1)
|
Huang et al.
|
TnT
|
NA
|
0.13 ng/mL
|
On ICU admission
|
60/60 (100)
|
19/60 (31.7)
|
Karbalai et al.
|
hs-cTnI
|
NA
|
26 ng/L for men, 11 ng/L for women
|
During hospitalisation
|
386/386 (100)
|
115/386 (29.8)
|
Lala et al.
|
TnI
|
Abbott
|
0.03 ng/mL
|
Within 24 h of admission
|
2736/3047 (89.8)
|
1751/2736 (36.0)
|
Lazzeri et al.
|
TnT
|
NA
|
0.028 ng/mL
|
On ICU admission
|
28/28 (100)
|
11/28 (39.3)
|
Li et al.
|
TnI
|
Beckman
|
0.03 ng/mL
|
On admission
|
82/82 (100)
|
13/82 (15.9)
|
Li et al.
|
hs-TnI
|
Abbott
|
34.2 ng/L
|
On admission
|
2068/2699 (76.6)
|
181/2068 (8.8)
|
Lombardi et al.
|
NA
|
NA
|
NA
|
Within 24 hours of admission
|
614/614 (100)
|
278/614 (45.3)
|
Lorente-Ros et al.
|
hs-TnI
|
NA
|
14 ng/L
|
On admission
|
707/707 (100)
|
148/707 (20.9)
|
Lu et al.
|
TnI
|
NA
|
0.4 ng/mL
|
During stay in ICU
|
50/72 (69.4)
|
36/50 (72.0)
|
Ma K, et al
|
TnI
|
NA
|
0.034 ng/mL
|
During hospitalisation
|
84/84 (100)
|
9/84 (10.7)
|
Majure et al.
|
TnI, TnI, TnT, hs-TnT
|
Siemens, Siemens, Roche, Roche
|
0.045 ng/mL, 0.056 ng/mL, 0.01 ng/mL, 19 ng/L
|
Within 48 hours of admission
|
6247/11,159 (56.0)
|
1821/6247 (29.1)
|
Mejía-Vilet et al.
|
TnI
|
NA
|
0.020 ng/mL
|
On admission
|
569/569 (100)
|
86/569 (15.1)
|
Nguyen et al.
|
hs-TnI
|
NA
|
22 ng/L
|
On admission
|
340/356 (95.5)
|
140/340 (41.2)
|
Nie et al.
|
hs-TnI
|
Abbott
|
26.2 ng/L
|
During hospitalisation
|
NA
|
103/311 (33.1)
|
Petrilli et al.
|
NA
|
NA
|
0.1 ng/mL
|
On admission
|
2510/2729 (92.0)
|
NA
|
Price-Haywood et al.
|
TnI
|
NA
|
0.06 ng/mL
|
On admission
|
1084/1382 (78.4)
|
270/1084 (24.9)
|
Qi et al.
|
hs-TnT
|
Roche
|
14 ng/L
|
On admission
|
76/267 (28.5)
|
3/76 (3.9)
|
Qin et al.
|
hs-TnI, TnI
|
Various
|
Various
|
On admission
|
1462/6033 (24.2)
|
95/1462 (6.5)
|
Raad et al.
|
hs-TnI
|
Beckman
|
18 ng/L
|
On admission
|
1020/1044 (97.7)
|
390/1020 (38.2)
|
Shah et al.
|
TnI
|
NA
|
0.05 ng/mL
|
During hospitalisation
|
309/635 (48.7)
|
116/309 (37.5)
|
Shah et al.
|
TnI
|
NA
|
0.05 ng/mL
|
During hospitalisation
|
14/26 (53.8)
|
5/14 (35.7)
|
Shen et al.
|
TnI
|
Siemens
|
0.040 ng/mL
|
On admission
|
325/325 (100)
|
80/325 (24.6)
|
Stefanini et al.
|
hs-TnI
|
Beckman
|
19.6 ng/L
|
On admission
|
397/397 (100)
|
130/397 (32.7)
|
Szekely et al.
|
TnI
|
Abbott
|
28 ng/L
|
On admission
|
100/100 (100)
|
20/100 (20)
|
Tan et al.
|
hs-TnI
|
Abbott
|
26.2 ng/L
|
On admission
|
115/115 (100)
|
20/115 (17.4)
|
van den Heuvel et al.
|
hs-TnT
|
Roche
|
14 ng/L
|
During hospitalisation
|
47/51 (92.2)
|
24/47 (51.1)
|
Wei et al.
|
hs-TnT
|
Roche
|
14 ng/L
|
On admission
|
101/103 (98.1)
|
16/101 (15.8)
|
Woo et al.
|
hs-TnT, TnI
|
Roche, Siemens
|
19 ng/L, 0.040 ng/mL
|
On admission
|
NA
|
NA
|
Xu et al.
|
TnI
|
NA
|
NA
|
On admission
|
15/15 (100)
|
1/15 (6.7)
|
Yang et al.
|
TnI
|
Siemens
|
0.040 ng/mL
|
On admission
|
463/463 (100)
|
45/463 (9.7)
|
Yu et al.
|
hs-TnI, TnI
|
Abbott, NA
|
28 ng/L, 0.3 ng/mL
|
During stay in ICU
|
226/226 (100)
|
61/226 (27.0)
|
Zeng et al.
|
TnI
|
NA
|
0.026 ng/mL
|
On admission
|
345/416 (82.9)
|
29/345 (8.4)
|
Zhang et al.
|
hs-TnT
|
Roche
|
14 ng/L
|
On admission
|
135/135 (100)
|
40/135 (29.6)
|
Zhao et al.
|
TnI
|
NA
|
0.01 ng/mL
|
On admission
|
88/91 (96.7)
|
3/88 (3.4)
|
Zhou et al.
|
hs-TnI
|
Abbott
|
28 ng/L
|
On admission
|
145/191 (75.9)
|
24/145 (16.6)
|